This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Mangrove fight with TransAlta tests Canada's commitment to shareholder rights

By Jason Booth ( April 18, 2019, 17:05 GMT | Comment) -- Activist Mangrove Partners calls its campaign to interrupt Brookfield's C$750 million (US$559 million) investment in TransAlta a test of Canada’s commitment to shareholder rights. Maybe so, but the odds of winning look long given the history of similar cases, highlighting the challenges faced by shareholder activists in Canada.Activist Mangrove Partners calls its campaign to interrupt Brookfield's C$750 million (US$559 million) investment in TransAlta a test of Canada’s commitment to shareholder rights. Maybe so, but the odds of winning look long given the history of similar cases, highlighting the challenges faced by shareholder activists in Canada....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login